Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2766-2769

  Wang, Jianxiang ^a   Saunthararajah, Yogen ^a   Redner, Robert L ^b   Liu, Johnson M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; HISTONE DEACETYLASE; TRICHOSTATIN A;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; ENZYME INHIBITION; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

3T3 CELLS; ACUTE DISEASE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA, MYELOID; MICE; NEOPLASM PROTEINS; PHENYLBUTYRATES; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033564130     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proc. Natl. Acad. Sci. USA, 88: 10431-10434, 1991.
2. Erickson, P., Gao, J., Chang, K-S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. D., and Drabkin, H. Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood, 80: 1825-1831, 1992.
3. Nisson, P. E., Watkins, P. C., and Sacchi, N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in the t(8;21) leukemic cells. Cancer Genet. Cytogenet., 63: 81-88, 1992.
4. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., and Ohki, M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 transcript. EMBO J., 12: 2715-2721, 1993.
5. Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., and Hirai, H. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J., 14: 341-350, 1995.
6. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. AML-1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84: 321-330, 1996.
7. Meyers, S., Lenny, N., and Hiebert, S. W. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol., 15: 1974-1982, 1995.
8. Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S. W., and Nimer, S. D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene, 11: 2667-2674, 1995.
9. Lenny, N., Meyers, S., and Hiebert, S. W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene, 11: 1761-1769, 1995.
10. Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marin-Padilla, M., Tenen, D. G., Speck, N. A., and Zhang, D-E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet., 15: 303-306, 1997.
11. Wang, J., Hoshino, T., Redner, R. L., Kajigaya, S., and Liu, J. M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA, 95: 10860-10865, 1998.
12. Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., and Evans, R. M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (Lond.), 391: 811-814, 1998.
13. Grignani, F., DeMatteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., Seiser, C., Grignani, F., Lazar, M. A., Minucci, S., and Pelicci, P. G. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature (Lond.), 391: 815-818, 1998.
14. Warrell, R. P., Jr., He, L. Z., Richon, V., Calleja, E., and Pandolfi, P. P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst., 90: 1621-1625, 1998.
15. Asou, H., Tashiro, S., Hamamoto, K., Otsuji, A., Kita, K., and Kamada, N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood, 77: 2031-2036, 1991.
16. Da Silva, N., Meyer-Monard, S., Menot, M. L., Degos, L., Baruchel, A., Dombret, H., and Chomienne, C. G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8;21) translocation: basis for potential therapeutic efficacy. Cytokines Cell. Mol. Ther., 3: 75-80, 1997.
17. Miyoshi, H., Ohki, M., Nakagawa, T., and Honma, Y. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation. Leuk. Res., 21: 45-50, 1997.
18. Wang, Z. G., Rivi, R., Delva, L., Konig, A., Scheinberg, D. A., Gambacorti-Passerini, C., Gabrilove, J. L., Warrell, R. P., Jr., and Pandolfi, P. P. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RAR alpha independent manner. Blood, 92: 1497-1504, 1998.
19. Soignet, S. L., Maslak, P., Wang, Z. G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., Pandolfi, P. P., and Warrell, R. P., Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide [see comments]. N. Engl. J. Med., 339: 1341-1348, 1998.
20. Sakakura, C., Yamaguchi-Iwai, Y., Satake, M., Bae, S-C., Takahashi, A., Ogawa, E., Hagiwara, A., Takahashi, T., Murakami, A., Makino, K., Nakagawa, T., Kamada, N., and Ito, Y. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc. Natl. Acad. Sci. USA, 91: 11723-11727, 1994.
21. Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., and Hiebert, S. W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol., 18: 322-333, 1998.